Methods for inhibiting the chemotaxis of neutrophils
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 16, 1997
Grant Date -
N/A
app pub date -
May 25, 1995
filing date -
Mar 7, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
An anti-inflammatory drug comprising as the effective component at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid and pharmaceutically acceptable salts thereof. The drug is used as a drug for renal diseases, a drug for hepatitis, an immunomodulator and a drug for inhibiting the chemotaxis of neutrophil.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully